Chromium Picolinate for the Treatment of Metabolic Syndrome

Summary

The purpose of this study is to determine whether chromium supplements can reduce symptoms of metabolic syndrome, a collection of symptoms that increase one's risk for developing heart disease, stroke, and diabetes.

Timeline

Start

2004-01

Primary completion

—

Completion

2005-12

Outcome

Missed primary endpoint

paper After 16 weeks of CrPic treatment, there was no significant change in insulin sensitivity index between groups (P = 0.14). PMID 19422140 ↗

Publications

• Iqbal N, Cardillo S, Volger S, Bloedon LT, Anderson RA, Boston R, Szapary PO. Chromium picolinate does not improve key features of metabolic syndrome in obese nondiabetic adults. Metab Syndr Relat Disord. 2009 Apr;7(2):143-50. doi: 10.1089/met.2008.0048.

Drugs

Indications